Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 9 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 9 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Immune Cell Cancer Biotech Gains $172M in New Funds

Natural killer cell

A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds

Trial Underway for Crispr Lymphoma Therapy

Crispr-Cas9

A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr. . . . → Read More: Trial Underway for Crispr Lymphoma Therapy

Biotechs Partner on Lower Cost AI-Designed Drugs

Artificial intelligence graphic

Two biotechnology companies are collaborating on discovery and development of new drugs designed with artificial intelligence, at lower cost to patients. . . . → Read More: Biotechs Partner on Lower Cost AI-Designed Drugs

Micro Brain Robot Granted Orphan Status

Brain tumor graphic

A tiny remote-controlled device that carries chemotherapy drugs to brain tumors received orphan drug status from the Food and Drug Administration. . . . → Read More: Micro Brain Robot Granted Orphan Status

Patent Awarded for Safer Cancer Drug Delivery

Chemotherapy vials

A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery

Precision Cancer Meds Company Raises $43M in Early Funds

Network pointer

A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round. . . . → Read More: Precision Cancer Meds Company Raises $43M in Early Funds

Small Biz Grant Funds Covid-19 Antiviral Therapy

SARS-CoV-2 particle

A biotechnology company developing cancer therapies is receiving an NIH grant to extend its technology for antiviral peptides against the SARS-CoV-2 virus. . . . → Read More: Small Biz Grant Funds Covid-19 Antiviral Therapy

MD Anderson, Broad Institute Partner on Rare Cancers

Cancer on clipboard

MD Anderson Cancer Center and the Broad Institute are developing a new research platform for better understanding rare types of cancer. . . . → Read More: MD Anderson, Broad Institute Partner on Rare Cancers

Biotechs Partner on Gene-Edited Cancer Cell Therapies

Natural killer cell

Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies

Cell Therapy Mfring Company Raises $82M in Venture Funds

T-cells and cancer cells

A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds